Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure with Preserved Ejection Fraction: A Randomized Clinical Trial

IMPORTANCE: Studies in experimental and human heart failure suggest that phosphodiesterase type-5 inhibitors may enhance cardiovascular function, and thus, exercise capacity in heart failure with preserved ejection fraction. OBJECTIVE: To determine the effect of the phosphodiesterase type-5 inhibito...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Redfield, Margaret M, Chen, Horng H, Borlaug, Barry A, Semigran, Marc J., Lee, Kerry L., Lewis, Gregory, LeWinter, Martin M., Rouleau, Jean L., Bull, David A., Mann, Douglas L., Deswal, Anita, Stevenson, Lynne W., Givertz, Michael M., Ofili, Elizabeth O., O’Connor, Christopher M., Felker, G. Michael, Goldsmith, Steven R., Bart, Bradley A., McNulty, Steven E, Ibarra, Jenny C., Lin, Grace, Oh, Jae K., Patel, Manesh R., Kim, Raymond J., Tracy, Russell P., Velazquez, Eric J., Anstrom, Kevin J., Hernandez, Adrian F., Mascette, Alice M., Braunwald, Eugene
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3835156/
https://ncbi.nlm.nih.gov/pubmed/23478662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2013.2024
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak